TNFRSF1B and neoplasm: These results indicate that in aberrant glycosylation conditions, TNFR1 can switch from the classical apoptotic signaling pathway activated by sTNFα to the one commonly attributed to TNFR2, which favors tumor progression by promoting cell proliferation.